secwatch.observer — SEC 8-K summary
======================================

Issuer:     Matinas BioPharma Holdings, Inc. (MTNB)
CIK:        0001582554
Form:       8-K
Filed at:   2025-01-24T23:59:59+00:00
Accession:  0001493152-25-003632
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
LLM model:  deepseek-v4-flash:cloud@v2

Matinas BioPharma director James Scibetta resigns from board effective Jan 21, 2025
--------------------------------------------------------------------------------

- James S. Scibetta resigned from the Board of Directors effective January 21, 2025.
- He also resigned from his positions on the Audit and Compensation Committees.
- Resignation was due to other professional obligations, not a material disagreement.
- No replacement director has been announced at this time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1582554/000149315225003632/0001493152-25-003632-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1582554/000149315225003632/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-003632

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer